JPWO2021163339A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021163339A5
JPWO2021163339A5 JP2022548450A JP2022548450A JPWO2021163339A5 JP WO2021163339 A5 JPWO2021163339 A5 JP WO2021163339A5 JP 2022548450 A JP2022548450 A JP 2022548450A JP 2022548450 A JP2022548450 A JP 2022548450A JP WO2021163339 A5 JPWO2021163339 A5 JP WO2021163339A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
hydrocarbyl
alkenyl
lipid particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513698A (ja
JP7843707B2 (ja
JP2023513698A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/017676 external-priority patent/WO2021163339A1/en
Publication of JP2023513698A publication Critical patent/JP2023513698A/ja
Publication of JPWO2021163339A5 publication Critical patent/JPWO2021163339A5/ja
Publication of JP2023513698A5 publication Critical patent/JP2023513698A5/ja
Application granted granted Critical
Publication of JP7843707B2 publication Critical patent/JP7843707B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548450A 2020-02-11 2021-02-11 肝星細胞への治療薬の脂質ナノ粒子送達のためのカチオン性脂質 Active JP7843707B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062975116P 2020-02-11 2020-02-11
US62/975,116 2020-02-11
PCT/US2021/017676 WO2021163339A1 (en) 2020-02-11 2021-02-11 Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells

Publications (4)

Publication Number Publication Date
JP2023513698A JP2023513698A (ja) 2023-04-03
JPWO2021163339A5 true JPWO2021163339A5 (https=) 2024-02-21
JP2023513698A5 JP2023513698A5 (https=) 2024-02-21
JP7843707B2 JP7843707B2 (ja) 2026-04-10

Family

ID=77292598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548450A Active JP7843707B2 (ja) 2020-02-11 2021-02-11 肝星細胞への治療薬の脂質ナノ粒子送達のためのカチオン性脂質

Country Status (11)

Country Link
US (1) US20230139594A1 (https=)
EP (1) EP4103172A4 (https=)
JP (1) JP7843707B2 (https=)
KR (1) KR20220140531A (https=)
CN (1) CN115697321A (https=)
AU (1) AU2021218409A1 (https=)
BR (1) BR112022015803A2 (https=)
CA (1) CA3170547A1 (https=)
IL (1) IL295441A (https=)
MX (1) MX2022009861A (https=)
WO (1) WO2021163339A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3364949A4 (en) * 2015-10-22 2019-07-31 ModernaTX, Inc. CANCER VACCINES
CN117045791B (zh) * 2023-03-22 2025-10-03 中国药科大学 肝星状细胞neu1的靶向过表达剂在制备治疗肝纤维化的药物中的应用
WO2025189064A1 (en) 2024-03-08 2025-09-12 Genzyme Corporation Lipid nanoparticles
JP2025168864A (ja) * 2024-04-30 2025-11-12 信越化学工業株式会社 含窒素多官能オルガノキシシラン化合物の製造方法
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026022656A2 (en) 2024-07-22 2026-01-29 Genevant Sciences Gmbh Lipid particle formulations with permanently charged cationic lipids
WO2026022677A1 (en) 2024-07-22 2026-01-29 Genevant Sciences Gmbh Permanently charged cationic lipids
WO2026030375A2 (en) 2024-07-30 2026-02-05 Genzyme Corporation Lipid nanoparticles and methods of manufacture and use thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB709345A (en) * 1950-08-28 1954-05-19 California Research Corp Unsymmetrical alkoxy (tri- and tetra-) siloxanes and processes for making the same
US2713064A (en) * 1953-12-07 1955-07-12 Dow Corning Bis-(trialkoxysilyl) benzenes and their use
US3029269A (en) * 1956-08-21 1962-04-10 California Research Corp Silicon esters
DE1180359B (de) * 1962-05-15 1964-10-29 Ruhrchemie Ag Verfahren zur kontinuierlichen Herstellung von Orthokieselsaeureestern
NL134718C (https=) * 1966-12-01
US3810843A (en) * 1971-05-28 1974-05-14 Gen Electric Silicone-silica compositions
CH632765A5 (de) * 1977-09-09 1982-10-29 Ciba Geigy Ag Verfahren zur herstellung von siliciummodifizierten phthalsaeurederivaten.
US4329486A (en) * 1981-06-29 1982-05-11 Olin Corporation Process for preparing alkoxysilane cluster compounds by reacting a trialkoxysilanol with an amidated alkoxysilane cluster compound
JPH086040B2 (ja) * 1990-10-26 1996-01-24 信越化学工業株式会社 オルガノポリシロキサン組成物
US5534592A (en) * 1995-09-22 1996-07-09 The Goodyear Tire & Rubber Company High performance blend for tire treads
EP1687830B1 (en) * 2003-11-28 2010-07-28 Merck Patent GmbH Organic semiconducting layer formulations comprising polyacenes and organic binder polymers
JP5401316B2 (ja) * 2006-09-29 2014-01-29 モメンティブ パフォーマンス マテリアルズ インコーポレイテッド 加水分解性有機官能性シランの部分および/または完全縮合物の貯蔵に安定な組成物
JP5316743B2 (ja) * 2007-11-01 2013-10-16 Jsr株式会社 ケイ素含有膜形成用組成物およびケイ素含有絶縁膜の形成方法
JP5133092B2 (ja) 2008-03-06 2013-01-30 花王株式会社 機能性物質放出剤
CN101724127A (zh) * 2008-10-16 2010-06-09 住友橡胶工业株式会社 聚合物、橡胶组合物及使用该橡胶组合物的轮胎
US9375484B2 (en) 2011-05-31 2016-06-28 Regents Of The University Of Minnesota Taxane silicate prodrugs and nanoparticles
CN102911401B (zh) 2012-11-08 2014-04-23 广州市回天精细化工有限公司 一种羟基清除剂、其制备方法及含有它的硫化硅橡胶
JP6614014B2 (ja) * 2016-04-26 2019-12-04 信越化学工業株式会社 含窒素オルガノキシシラン化合物およびその製造方法
DE102017221259A1 (de) * 2017-11-28 2019-05-29 Evonik Degussa Gmbh Silanmischungen und Verfahren zu deren Herstellung
JP6865898B2 (ja) * 2017-12-21 2021-04-28 スリーエム イノベイティブ プロパティズ カンパニー シラン処理された表面を有する歯科用無機充填剤
CN108239103B (zh) 2018-01-02 2020-09-01 深圳市广业电子科技有限公司 一种含有多肟基硅的硅氮化合物
CA3105394A1 (en) * 2018-07-02 2020-01-09 Aptamir Therapeutics, Inc. Targeted delivery of therapeutic agents to human adipocytes
AU2021403156A1 (en) * 2020-12-18 2023-07-13 Genevant Sciences Gmbh Peg lipids and lipid nanoparticles

Similar Documents

Publication Publication Date Title
Ickenstein et al. Lipid-based nanoparticle formulations for small molecules and RNA drugs
Rietwyk et al. Next-generation lipids in RNA interference therapeutics
JP2023071947A (ja) Rna送達のためのイオン化可能なカチオン性脂質
JP6077509B2 (ja) 改良されたアミノ脂質および核酸の送達方法
KR101948839B1 (ko) 음이온성 약물 함유 약제학적 조성물 및 그 제조방법
CN101291653B (zh) 脂质包封的干扰rna
JP2002501511A (ja) 脂質小胞への荷電した治療剤の高率封入
EP2410988A1 (en) Pharmaceutical composition containing a drug and sirna
US20240115730A1 (en) Tissue-specific nucleic acid delivery by 1,2-dioleoyl-3-trimethylammonium-propane (dotap) lipid nanoparticles
JP2010510327A (ja) エンドキシフェンの方法および組成物
TW201717914A (zh) 用於奈米顆粒冷凍乾燥形式的組成物及方法
JPWO2021163339A5 (https=)
JP2004508012A (ja) エンドソーム膜不安定剤を用いたsplp媒介性トランスフェクションの強化方法
KR20240082390A (ko) 생분해성 에스터 결합을 포함하는 이온화 가능한 지질 및 이를 포함하는 지질나노입자
KR102911928B1 (ko) 신규 이온화 가능한 지질 및 이를 포함하는 지질나노입자
JP2025501905A (ja) イオン化脂質、脂質ナノ粒子、及びこれらの使用
Oussoren et al. The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs
WO2017048018A1 (ko) 음이온성 약물 함유 약제학적 조성물 및 그 제조방법
JP2011520936A5 (https=)
KR20240083166A (ko) 폐를 표적장기로 하는 생분해성 지질나노입자 약물 전달 제형 및 이의 활용
WO2024019770A1 (en) Methods of making ionizable lipids and lipid nanoparticles for mrna delivery
JPWO2023144798A5 (https=)
JPWO2021188389A5 (https=)
KR20240109177A (ko) 가지 친 구조의 이온화 지질을 포함한 지질 나노입자 제형 및 이의 용도
NL2019801B1 (en) Delivery vectors